Efficacy and safety comparison of liraglutide, glimepiride, and placebo all in combination with metformin in type 2 diabetes mellitus (LEAD-2 Met)
No human trials as of June 2026
She said, If you ever want to drop 5 pounds, this is good, Handler recalled
A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who took GLP-1 medications were about 30% less likely to develop breast cancer than those who did not take GLP-1 medications, according to research presented today at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting (Abstract 10506) by Elizabeth McDonald, MD, PhD, a professor of Radiology in the University of Pennsylvania Perelman School of Medicine and a practicing breast radiologist at Penns Abramson Cancer Center
Most people begin to see clinically meaningful weight loss between 3 and 6 months, with variations depending on dose, adherence, diet, exercise, and individual metabolism